CHICAGO, Sept. 07, 2017 -- In the second quarter of 2017, Rothman Institute selected Allscripts (NASDAQ:MDRX) Practice Management as its core financial platform, replacing its legacy system. Allscripts PM will help Rothman Institute manage scheduling, collections, claims and denials, maximizing the organization’s revenue.
Rothman Institute, based in Philadelphia, PA, is a global leader in Orthopedic science and technology. Rothman Institute’s sports medicine team evaluates more than 80,000 sports injuries and performs more than 10,000 surgeries each year. Additionally, Rothman’s clinical staff serves as team physicians for the Philadelphia Eagles, Philadelphia Flyers, Philadelphia 76ers and more than 40 local high schools and colleges.
Allscripts PM is a comprehensive revenue cycle management solution for physician practices and large hospital organizations. The solution helps physicians addresses some of the challenges they face today such as shifting from fee-for-service to value-based care, consolidation, meeting complex regulations and maximizing reimbursement. Allscripts PM’s open architecture enables the sharing of patient information across multiple platforms and streamlines accounts receivable.
“Rothman Institute chose the Allscripts Practice Management solution because it closely aligns with our goals to continuously improve our financial and operational performance,” said Rothman Institute’s Chief Information Officer, Lancer Seaman. “The solution provides the tools we need to enhance revenue cycle operations and increase efficiencies of reimbursement processes and patient payments.”
"We are honored to partner with the Rothman Institute to help the prestigious organization navigate the challenging financial and operational landscape of today’s healthcare IT industry,” said Allscripts Senior Vice President and General Manager Ambulatory Business Unit, Steve Lalonde. “Our goal is to help Rothman Institute get reimbursed for the services they provide and free up time and resources so they can focus on providing quality care to its community.”
About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2017 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
For more information contact: Investors: Seth Frank 312-506-1213 [email protected] Media: Concetta Rasiarmos 312-447-2466 [email protected]


Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Washington Post Publisher Will Lewis Steps Down After Layoffs
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Instagram Outage Disrupts Thousands of U.S. Users
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 



